Erlotinib induced ectropion following papulopustular rash
[摘要] Erlotinib is a targeted anti-cancer drug which acts through the inhibition of epidermal growth factor receptor (EGFR).
[发布日期] [发布机构]
[效力级别] [学科分类] 皮肤病学
[关键词] adverse effects;ectropion;eye;erlotinib;papulopustular rash [时效性]
